Oncobell is a joint research program focused on molecular mechanisms and experimental therapies in cancer. It is a new program within the IDIBELL with the aim to fight cancer in a collective and multidisciplinary way. It includes an array of groups that cover the stages from basic frontier research all the way to clinical treatments of the patients.
The common nominator of the program is that all groups work on improving patients’ outcomes through either a molecular/pathway oriented approach or through a disease and clinical needs oriented approach. We believe that increasing the communication between groups linking these two approaches will lead to better ideas and shortcuts in the transition between lab results into the clinics.
More information: http://oncobellsymposium.idibell.cat/